Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuomi, T.
Right arrow Articles by Groop, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuomi, T.
Right arrow Articles by Groop, L. C.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 1 150-157, Copyright © 1999 by American Diabetes Association

ARTICLES

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies

T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissen, BO Ehrnstrom, B Forsen, B Snickars, K Lahti, C Forsblom, C Saloranta, MR Taskinen and LC Groop
Department of Endocrinology, Lund University, Sweden. tiinamaija.tuomi@endo.mas.lu.se

The aim of the study was 1) to establish the prevalence of GAD antibodies (GADab) in a population-based study of type 2 diabetes in western Finland, 2) to genetically and phenotypically characterize this subgroup, and 3) to provide a definition for latent autoimmune diabetes in adults (LADA). The prevalence of GADab was 9.3% among 1,122 type 2 diabetic patients, 3.6% among 558 impaired glucose tolerance (IGT) subjects, and 4.4% among 383 nondiabetic control subjects. Islet antigen 2 antibodies (IA2ab) or islet cell antibodies were detected in only 0.5% of the GADab- patients. The GADab+ patients had lower fasting C-peptide concentrations (median [interquartile range]: 0.46 [0.45] vs. 0.62 [0.44] nmol/l, P = 0.0002) and lower insulin response to oral glucose compared with GADab- patients. With respect to features of the metabolic syndrome, the GADab+ patients had lower systolic (140 [29.1] vs. 148 [26.0] mmHg, P = 0.009) and diastolic (79.2 [17.6] vs. 81.0 [13.1] mmHg, P = 0.030) blood pressure values, as well as lower triglyceride concentrations (1.40 [1.18] vs. 1.75 [1.25] mmol/l, P = 0.003). GADab+ men had a lower waist-to-hip ratio compared with GADab- patients. Compared with GADab- patients and control subjects, the GADab+ patients had an increased frequency HLA-DQB1*0201/0302 (13 vs. 4%; P = 0.002) and other genotypes containing the *0302 allele (22 vs. 12%; P = 0.010). However, the frequency of these high-risk genotypes was significantly lower in GADab+ type 2 patients than in type 1 diabetes of young or adult onset (0201/0302 or 0302/X: 36 vs. 66 vs. 64%, P < 0.001). The GADab+ type 2 group did not differ from control subjects with respect to genotypes containing the protective DQB1-alleles *0602 or *0603, nor with respect to the type 1 high-risk genotype in the IDDM1 (Hph1 +/+). We conclude that GADab+ patients differ from both GADab- type 2 diabetic patients and type 1 diabetic patients with respect to beta-cell function, features of the metabolic syndrome, and type 1 diabetes susceptibility genes. Further, we propose that LADA be defined as GADab positivity (>5 relative units) in patients older than 35 years at onset of type 2 diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
A. K. Steck and G. S. Eisenbarth
Genetic Similarities Between Latent Autoimmune Diabetes and Type 1 and Type 2 Diabetes
Diabetes, May 1, 2008; 57(5): 1160 - 1162.
[Full Text] [PDF]

Home page
 DiabetesHome page
C. Cervin, V. Lyssenko, E. Bakhtadze, E. Lindholm, P. Nilsson, T. Tuomi, C. M. Cilio, and L. Groop
Genetic Similarities Between Latent Autoimmune Diabetes in Adults, Type 1 Diabetes, and Type 2 Diabetes
Diabetes, May 1, 2008; 57(5): 1433 - 1437.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Goel, H. Chiu, J. Felton, J. P. Palmer, and B. Brooks-Worrell
T-Cell Responses to Islet Antigens Improves Detection of Autoimmune Diabetes and Identifies Patients With More Severe {beta}-Cell Lesions in Phenotypic Type 2 Diabetes
Diabetes, August 1, 2007; 56(8): 2110 - 2115.
[Abstract] [Full Text] [PDF]

Home page
 J HeredHome page
A. D. Short, B. Catchpole, L. J. Kennedy, A. Barnes, N. Fretwell, C. Jones, W. Thomson, and W. E.R. Ollier
Analysis of Candidate Susceptibility Genes in Canine Diabetes
J. Hered., July 4, 2007; (2007) esm048v1.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A Mayer, N Fabien, M C Gutowski, V Dubois, L Gebuhrer, J Bienvenu, J Orgiazzi, and A M Madec
Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adults
Eur. J. Endocrinol., July 1, 2007; 157(1): 53 - 61.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Buzzetti, S. Di Pietro, A. Giaccari, A. Petrone, M. Locatelli, C. Suraci, M. Capizzi, M. L. Arpi, E. Bazzigaluppi, F. Dotta, et al.
High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune Diabetes
Diabetes Care, April 1, 2007; 30(4): 932 - 938.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Barinas-Mitchell, L. H. Kuller, S. Pietropaolo, Y.-J. Zhang, T. Henderson, and M. Pietropaolo
The Prevalence of the 65-Kilodalton Isoform of Glutamic Acid Decarboxylase Autoantibodies by Glucose Tolerance Status in Elderly Patients from the Cardiovascular Health Study
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2871 - 2877.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Desai, E. Zeggini, V. A. Horton, K. R. Owen, A. T. Hattersley, J. C. Levy, G. A. Hitman, M. Walker, R. R. Holman, M. I. McCarthy, et al.
The Variable Number of Tandem Repeats Upstream of the Insulin Gene Is a Susceptibility Locus for Latent Autoimmune Diabetes in Adults
Diabetes, June 1, 2006; 55(6): 1890 - 1894.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Fourlanos, C. Perry, M. S. Stein, J. Stankovich, L. C. Harrison, and P. G. Colman
A Clinical Screening Tool Identifies Autoimmune Diabetes in Adults
Diabetes Care, May 1, 2006; 29(5): 970 - 975.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
G. E. Umpierrez, D. Smiley, and A. E. Kitabchi
Narrative review: ketosis-prone type 2 diabetes mellitus.
Ann Intern Med, March 7, 2006; 144(5): 350 - 357.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S Genovese, E Bazzigaluppi, D Goncalves, A Ciucci, M G Cavallo, F Purrello, M Anello, C M Rotella, G Bardini, O Vaccaro, et al.
Clinical phenotype and {beta}-cell autoimmunity in Italian patients with adult-onset diabetes.
Eur. J. Endocrinol., March 1, 2006; 154(3): 441 - 447.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Ronnback, B. Isomaa, J. Fagerudd, C. Forsblom, P.-H. Groop, T. Tuomi, L. Groop, and for the Botnia Study Group
Complex Relationship Between Blood Pressure and Mortality in Type 2 Diabetic Patients: A Follow-Up of the Botnia Study
Hypertension, February 1, 2006; 47(2): 168 - 173.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Tuomi
Type 1 and Type 2 Diabetes: What Do They Have in Common?
Diabetes, December 1, 2005; 54(suppl_2): S40 - S45.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark
Autoantibodies in Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S52 - S61.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. Stenstrom, A. Gottsater, E. Bakhtadze, B. Berger, and G. Sundkvist
Latent Autoimmune Diabetes in Adults: Definition, Prevalence, {beta}-Cell Function, and Treatment
Diabetes, December 1, 2005; 54(suppl_2): S68 - S72.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
I. Vauhkonen, L. Niskanen, M. Knip, L. M. Mykkanen, S. Haffner, M. Uusitupa, and M. Laakso
Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults
Eur. J. Endocrinol., August 1, 2005; 153(2): 265 - 273.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. W. S. Rosario, J. S. Reis, R. Amim, T. A. Fagundes, M. R. Calsolari, S. C. Silva, and S. Purisch
Comparison of Clinical and Laboratory Characteristics Between Adult-Onset Type 1 Diabetes and Latent Autoimmune Diabetes in Adults
Diabetes Care, July 1, 2005; 28(7): 1803 - 1804.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. Biesenbach, M. Auinger, M. Clodi, F. Prischl, R. Kramar, and Diabetic Nephropathy Study Group of the Austrian S
Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria
Nephrol. Dial. Transplant., March 1, 2005; 20(3): 559 - 565.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. Engstrom, B. Hedblad, K.-F. Eriksson, L. Janzon, and F. Lindgarde
Complement C3 Is a Risk Factor for the Development of Diabetes: A Population-Based Cohort Study
Diabetes, February 1, 2005; 54(2): 570 - 575.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
A. A. Motala, M. Busson, E. M. Al-Harbi, M. A. A. Khuzam, E. M. D. Al-Omari, M. R. Arekat, and W. Y. Almawi
Susceptible and Protective Human Leukocyte Antigen Class II Alleles and Haplotypes in Bahraini Type 2 (Non-Insulin-Dependent) Diabetes Mellitus Patients
Clin. Vaccine Immunol., January 1, 2005; 12(1): 213 - 217.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. Zinman, S. E. Kahn, S. M. Haffner, M. C. O'Neill, M. A. Heise, M. I. Freed, and ADOPT Study Group*
Phenotypic Characteristics of GAD Antibody-Positive Recently Diagnosed Patients With Type 2 Diabetes in North America and Europe
Diabetes, December 1, 2004; 53(12): 3193 - 3200.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Maioli, E. Alejandro, G. Tonolo, L. K. Gilliam, L. Bekris, C. S. Hampe, D. A. Obinu, A. Manconi, L. Puddu, K. Lynch, et al.
Epitope-Restricted 65-Kilodalton Glutamic Acid Decarboxylase Autoantibodies among New-Onset Sardinian Type 2 Diabetes Patients Define Phenotypes of Autoimmune Diabetes
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5675 - 5682.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Murao, H. Makino, Y. Kaino, E. Konoue, J. Ohashi, K. Kida, Y. Fujii, I. Shimizu, E. Kawasaki, M. Fujiyama, et al.
Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients
Diabetes, October 1, 2004; 53(10): 2684 - 2690.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
S Ehtisham, A T Hattersley, D B Dunger, and T G Barrett
First UK survey of paediatric type 2 diabetes and MODY
Arch. Dis. Child., June 1, 2004; 89(6): 526 - 529.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. Barinas-Mitchell, S. Pietropaolo, Y.-J. Zhang, T. Henderson, M. Trucco, L. H. Kuller, and M. Pietropaolo
Islet Cell Autoimmunity in a Triethnic Adult Population of the Third National Health and Nutrition Examination Survey
Diabetes, May 1, 2004; 53(5): 1293 - 1302.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Domanski and M. Proschan
The metabolic syndrome
J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1396 - 1398.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Glumer, B. Carstensen, A. Sandbaek, T. Lauritzen, T. Jorgensen, and K. Borch-Johnsen
A Danish Diabetes Risk Score for Targeted Screening: The Inter99 study
Diabetes Care, March 1, 2004; 27(3): 727 - 733.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. P. Palmer, G. A. Fleming, C. J. Greenbaum, K. C. Herold, L. D. Jansa, H. Kolb, J. M. Lachin, K. S. Polonsky, P. Pozzilli, J. S. Skyler, et al.
C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve {beta}-Cell Function: Report of an ADA Workshop, 21-22 October 2001
Diabetes, January 1, 2004; 53(1): 250 - 264.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. E. Kitabchi
Ketosis-Prone Diabetes--A New Subgroup of Patients with Atypical Type 1 and Type 2 Diabetes?
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5087 - 5089.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Maldonado, C. S. Hampe, L. K. Gaur, S. D'Amico, D. Iyer, L. P. Hammerle, D. Bolgiano, L. Rodriguez, A. Rajan, A. Lernmark, et al.
Ketosis-Prone Diabetes: Dissection of a Heterogeneous Syndrome Using an Immunogenetic and {beta}-Cell Functional Classification, Prospective Analysis, and Clinical Outcomes
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5090 - 5098.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. R. Owen, A. Stride, S. Ellard, and A. T. Hattersley
Etiological Investigation of Diabetes in Young Adults Presenting With Apparent Type 2 Diabetes
Diabetes Care, July 1, 2003; 26(7): 2088 - 2093.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Li, L. Groop, A. Nilsson, J. Weng, and T. Tuomi
A Combination of Human Leukocyte Antigen DQB1*02 and the Tumor Necrosis Factor {alpha} Promoter G308A Polymorphism Predisposes to an Insulin-Deficient Phenotype in Patients with Type 2 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2767 - 2774.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
N. Hosszufalusi, A. Vatay, K. Rajczy, Z. Prohaszka, E. Pozsonyi, L. Horvath, A. Grosz, L. Gero, L. Madacsy, L. Romics, et al.
Similar Genetic Features and Different Islet Cell Autoantibody Pattern of Latent Autoimmune Diabetes in Adults (LADA) Compared With Adult-Onset Type 1 Diabetes With Rapid Progression
Diabetes Care, February 1, 2003; 26(2): 452 - 457.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. P. Palmer and I. B. Hirsch
What's in a Name: Latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes
Diabetes Care, February 1, 2003; 26(2): 536 - 538.
[Full Text] [PDF]

Home page
 Am J EpidemiolHome page
G. Stenstrom, B. Berger, H. Borg, P. Fernlund, J. S. Dorman, and G. Sundkvist
HLA-DQ Genotypes in Classic Type 1 Diabetes and in Latent Autoimmune Diabetes of the Adult
Am. J. Epidemiol., November 1, 2002; 156(9): 787 - 796.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. S. Hampe, I. Kockum, M. Landin-Olsson, C. Torn, E. Ortqvist, B. Persson, O. Rolandsson, J. Palmer, and A. Lernmark
GAD65 Antibody Epitope Patterns of Type 1.5 Diabetic Patients Are Consistent With Slow-Onset Autoimmune Diabetes
Diabetes Care, August 1, 2002; 25(8): 1481 - 1482.
[Full Text]

Home page
 Diabetes CareHome page
H. Takeda, E. Kawasaki, I. Shimizu, E. Konoue, M. Fujiyama, S. Murao, K. Tanaka, K. Mori, Y. Tarumi, I. Seto, et al.
Clinical, Autoimmune, and Genetic Characteristics of Adult-Onset Diabetic Patients With GAD Autoantibodies in Japan (Ehime Study)
Diabetes Care, June 1, 2002; 25(6): 995 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Borg, A. Gottsater, P. Fernlund, and G. Sundkvist
A 12-Year Prospective Study of the Relationship Between Islet Antibodies and {beta}-Cell Function At and After the Diagnosis in Patients With Adult-Onset Diabetes
Diabetes, June 1, 2002; 51(6): 1754 - 1762.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. M. Lindgren, E. Widen, T. Tuomi, H. Li, P. Almgren, T. Kanninen, O. Melander, J. Weng, M. Lehto, and L. C. Groop
Contribution of Known and Unknown Susceptibility Genes to Early-Onset Diabetes in Scandinavia: Evidence for Heterogeneity
Diabetes, May 1, 2002; 51(5): 1609 - 1617.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. L. Lethagen, U.-B. Ericsson, B. Hallengren, L. Groop, and T. Tuomi
Glutamic Acid Decarboxylase Antibody Positivity Is Associated with an Impaired Insulin Response to Glucose and Arginine in Nondiabetic Patients with Autoimmune Thyroiditis
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1177 - 1183.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Napolitano, I. Bucci, C. Giuliani, C. Massafra, C. Di Petta, E. Devangelio, D. S. Singer, F. Monaco, and L. D. Kohn
High Glucose Levels Increase Major Histocompatibility Complex Class I Gene Expression in Thyroid Cells and Amplify Interferon-{gamma} Action
Endocrinology, March 1, 2002; 143(3): 1008 - 1017.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Weng, M. Ekelund, M. Lehto, H. Li, G. Ekberg, A. Frid, A. Aberg, L. C. Groop, and K. Berntorp
Screening for MODY Mutations, GAD Antibodies, and Type 1 Diabetes- Associated HLA Genotypes in Women With Gestational Diabetes Mellitus
Diabetes Care, January 1, 2002; 25(1): 68 - 71.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Gambelunghe, M. Ghaderi, C. Tortoioli, A. Falorni, F. Santeusanio, P. Brunetti, C. B. Sanjeevi, and A. Falorni
Two Distinct MICA Gene Markers Discriminate Major Autoimmune Diabetes Types
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3754 - 3760.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Pozzilli and U. Di Mario
Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult): Definition, characterization, and potential prevention
Diabetes Care, August 1, 2001; 24(8): 1460 - 1467.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Borg, A. Gottsater, M. Landin-Olsson, P. Fernlund, and G. Sundkvist
High Levels of Antigen-Specific Islet Antibodies Predict Future {beta}-Cell Failure in Patients with Onset of Diabetes in Adult Age
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3032 - 3038.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
E. H. Hathout, W. Thomas, M. El-Shahawy, F. Nahab, and J. W. Mace
Diabetic Autoimmune Markers in Children and Adolescents With Type 2 Diabetes
Pediatrics, June 1, 2001; 107(6): e102 - 102.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. C.Y. Ng, S.-C. Lee, G. T.C. Ko, J. K.Y. Li, W.-Y. So, Y. Hashim, A. H. Barnett, I. R. Mackay, J. A.J.H. Critchley, C. S. Cockram, et al.
Familial Early-Onset Type 2 Diabetes in Chinese Patients: Obesity and genetics have more significant roles than autoimmunity
Diabetes Care, April 1, 2001; 24(4): 663 - 671.
[Abstract] [Full Text]

Home page
 Diabetes CareHome page
B. Isomaa, P. Almgren, T. Tuomi, B. Forsén, K. Lahti, M. Nissén, M.-R. Taskinen, and L. Groop
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Diabetes Care, April 1, 2001; 24(4): 683 - 689.
[Abstract] [Full Text]

Home page
 DiabetesHome page
R. Mallone, E. Ortolan, G. Baj, A. Funaro, S. Giunti, E. Lillaz, F. Saccucci, M. Cassader, P. Cavallo-Perin, and F. Malavasi
Autoantibody Response to CD38 in Caucasian Patients With Type 1 and Type 2 Diabetes: Immunological and Genetic Characterization
Diabetes, April 1, 2001; 50(4): 752 - 762.
[Abstract] [Full Text]

Home page
 GutHome page
B Wesche, E Jaeckel, C Trautwein, H Wedemeyer, A Falorni, H Frank, A von zur Muhlen, M-P Manns, and G Brabant
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C
Gut, March 1, 2001; 48(3): 378 - 383.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Parker, J. Meyer, S. Lewitzky, J. S. Rennich, G. Chan, J. D. Thomas, M. Orho-Melander, M. Lehtovirta, C. Forsblom, A. Hyrkkö, et al.
A Gene Conferring Susceptibility to Type 2 Diabetes in Conjunction With Obesity Is Located on Chromosome 18p11
Diabetes, March 1, 2001; 50(3): 675 - 680.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Li, E. Lindholm, P. Almgren, A. Gustafsson, C. Forsblom, L. Groop, and T. Tuomi
Possible Human Leukocyte Antigen-Mediated Genetic Interaction between Type 1 and Type 2 Diabetes
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 574 - 582.
[Abstract] [Full Text]

Home page
 DiabetesHome page
C. J. Greenbaum, D. Cuthbertson, and J. P. Krischer
Type 1 Diabetes Manifested Solely by 2-h Oral Glucose Tolerance Test Criteria
Diabetes, February 1, 2001; 50(2): 470 - 476.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Carlsson, G. Sundkvist, L. Groop, and T. Tuomi
Insulin and Glucagon Secretion in Patients with Slowly Progressing Autoimmune Diabetes (LADA)
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 76 - 80.
[Abstract] [Full Text]
</

 Home page
 J. Clin. Endocrinol. Metab.Home page
A. Falorni, G. Gambelunghe, F. Forini, G. Kassi, A. Cosentino, P. Candeloro, G. B. Bolli, P. Brunetti, and F. Calcinaro
Autoantibody Recognition of COOH-Terminal Epitopes of GAD65 Marks the Risk for Insulin Requirement in Adult-Onset Diabetes Mellitus
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 309 - 316.
[Abstract] [Full Text]